HGNNLDA:通过双通道超图神经网络预测 lncRNA-药物敏感性关联
概括
这项研究介绍了HGNNLDA,这是一种用于预测长非编码RNA (lncRNA) -药物敏感性关联的新计算方法. HGNNLDA有效地确定了这些关键联系,推动了个性化医疗和药物开发.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物敏感性是个性化癌症治疗的关键.
- 长非编码RNAs (lncRNAs) 通过调节基因来影响药物疗效.
- 目前用于识别 lncRNA-药物关联的方法在规模和效率上是有限的.
研究的目的:
- 开发一个高效的计算框架来预测 lncRNA-药物敏感性关联.
- 建立一种用于探索 lncRNAs 和药物敏感性之间的关系的新方法.
主要方法:
- 开发了HGNNLDA,一种双通道超图神经网络模型.
- 利用超图神经网络来捕捉 lncRNA-药物网络中的高阶相互作用.
- 采用联合更新机制来生成 lncRNA 和药物嵌入.
主要成果:
- 在预测 lncRNA-药物敏感性关联方面,HGNNLDA显著超过了六种最先进的模型.
- 案例研究表明,HGNNLDA在识别相关的 lncRNA-药物联系方面具有有效性.
- 超图的方法有效地模拟了复杂的,高阶关系.
结论:
- HGNNLDA 是第一个用于预测 lncRNA-药物敏感性关联的计算框架.
- 拟议的方法为药物开发和个性化治疗策略提供了可扩展和有效的方法.
- HGNNLDA促进了对 lncRNA 在药物反应中的作用的理解.
更多相关视频
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.2K
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
287
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Drug-Receptor Interactions
5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
